Drug Class
antibody-drug conjugate
Type
brand
Active Ingredient
gemtuzumab ozogamicin
📋Overview
Mylotarg is a medication that contains gemtuzumab ozogamicin, an antibody-drug conjugate used in oncology. It is primarily associated with the treatment of certain types of acute myeloid leukemia (AML), a cancer of the blood and bone marrow. Mylotarg works by targeting specific cells involved in this disease. Its use is generally reserved for specific patient populations based on disease characteristics.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Mylotarg
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.